Category Archives: News

SOM Biotech at the “AI-Driven Drug Repositioning & Repurposing” Event

AI-Driven Drug Repositioning & Repurposing

SOM Biotech will attend the “AI-Driven Drug Repositioning & Repurposing” digital congress on April 20th – 21st. Organized by Hanson Wade, the “AI-Driven Drug Repositioning & Repurposing” event aims at featuring real-life case studies and experiences from companies that prove that introducing artificial intelligence in drug repurposing and repositioning is a game-changer in the industry, …

SOM Biotech to participate at the BIO-Europe Spring

Bio-Europe Spring 2021

SOM Biotech announces its participation in the BIO-Europe Spring 2021 partnering event on March 22nd – 25th, which will take place digitally due to the pandemic situation. Organized by the EBD Group, a global partnering event organizer, the BIO-Europe Spring event attracts leading decision-makers not only from the traditional pharma and biotech sectors but also …

SOM Biotech at Chiba Healthcare Business Forum 2021

SOM Biotech ends 2020 with an advanced and robust pipeline

SOM Biotech will attend the “Chiba Global Healthcare Business Forum 2021” on February 3rd – 4th, which will take place digitally due to the pandemic situation. Organized by the Japanese External Trade Association, the Chiba Healthcare Business Forum attracts the most advanced academic and research institutions as well as healthcare and life science companies worldwide …

SOM Biotech ends 2020 with an advanced and robust pipeline that strengthens the company’s future

SOM Biotech ends a notable year 2020

SOM Biotech ends the notable year 2020 with relevant advances in its pipeline. The company started 2020 with positive results from the Phase 2a proof-of-concept to evaluate the safety and efficacy of SOM3355, an inhibitor of the Vesicular Monoamine Transporter-2 (VMAT2), in Huntington´s disease (HD) patients with chorea. The clinical efficacy of SOM3355 in reducing …

SOM Biotech at the BIO- Partnering JPM Virtual Event 2021

SOM Biotech announces its participation at the BIO-Partnering at JP Morgan Healthcare Conference 2021, being held virtually on January 11th – 15th. The conference, a leading virtual partnering and business development initiative for the biotechnology industry organized by Biotechnology Innovation Organization, provides a One-on-One partnering platform to give companies access to potential strategic partners and …

European Biotechnology: “A pioneering real AI drug discovery technology”

A pioneering real AI drug discovery technology

European Biotechnology Life Science and Industry Magazine published the article “A pioneering real AI drug discovery technology” describing the approach of SOM Biotech. The current COVID-19 pandemic situation has shown that repurposing drugs can be crucial for delivering new treatments to patients with agility. Existing drugs can be developed to bring fast, safe and cost-effective …

La Vanguardia press release: “The future of biotechnology: lower-cost treatments in a short period of time”

La Vanguardia published a press release: “The future of biotechnology: lower-cost treatments in a short period of time”. You can find a short overview of the press release below. SOM Biotech has designed a computational Artificial Intelligence-based method to analyze molecular structures and select the best option after performing more than 2.5 million comparisons in …

SOM Biotech keynote speaker at the Drug Discovery Innovation Programme Virtual Event 2020

SOM Biotech ends 2020 with an advanced and robust pipeline

SOM Biotech announces its participation at the Drug Discovery Innovation Programme event 2020, being held virtually on November 17th. The conference will be chaired by Kevin McAllister, PhD, MBA Chief Scientific Officer. As a keynote speaker, Maria Zimina, PhD. MBA, Business Development Manager, will present “AI Evolutionary Algorithms for the Identification of Non-Structural Analogs: Case …